Adaptive Biotechnologies Corporation
ADPT
$7.47
$0.060.81%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 222.29M | 243.33M | 291.88M | 308.87M | 346.40M |
| Total Receivables | 43.03M | 42.11M | 36.81M | 43.12M | 38.97M |
| Inventory | 8.44M | 11.96M | 13.21M | 13.29M | 14.45M |
| Prepaid Expenses | 9.99M | 10.95M | 9.65M | 8.75M | 10.37M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 283.75M | 308.35M | 351.55M | 374.03M | 410.19M |
|
|
|||||
| Total Current Assets | 283.75M | 308.35M | 351.55M | 374.03M | 410.19M |
| Net Property, Plant & Equipment | 94.38M | 97.84M | 103.94M | 116.26M | 120.32M |
| Long-term Investments | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M |
| Goodwill | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M |
| Total Other Intangibles | 3.43M | 3.85M | 4.28M | 4.71M | 5.13M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.18M | 5.63M | 6.13M | 6.35M | 6.52M |
| Total Assets | 539.38M | 558.51M | 584.87M | 620.32M | 661.13M |
|
|
|||||
| Total Accounts Payable | 7.27M | 7.35M | 9.87M | 12.17M | 7.72M |
| Total Accrued Expenses | 20.67M | 18.40M | 16.23M | 14.32M | 20.39M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.10M | 10.02M | 9.81M | 9.59M | 9.38M |
| Total Finance Division Other Current Liabilities | 59.02M | 51.86M | 52.23M | 46.87M | 50.53M |
| Total Other Current Liabilities | 59.02M | 51.86M | 52.23M | 46.87M | 50.53M |
| Total Current Liabilities | 98.05M | 87.63M | 88.13M | 82.95M | 88.02M |
|
|
|||||
| Total Current Liabilities | 98.05M | 87.63M | 88.13M | 82.95M | 88.02M |
| Long-Term Debt | 132.41M | 132.70M | 132.08M | 131.55M | 130.66M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 79.15M | 81.80M | 84.37M | 86.90M | 89.39M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 27.28M | 32.80M | 38.86M | 44.16M | 44.79M |
| Total Liabilities | 336.89M | 334.93M | 343.44M | 345.56M | 352.86M |
|
|
|||||
| Common Stock & APIC | 1.51B | 1.49B | 1.48B | 1.47B | 1.45B |
| Retained Earnings | -1.30B | -1.27B | -1.24B | -1.19B | -1.14B |
| Treasury Stock & Other | 166.00K | 497.00K | -182.00K | -106.00K | 215.00K |
| Total Common Equity | 202.71M | 223.77M | 241.60M | 274.91M | 308.40M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 202.71M | 223.77M | 241.60M | 274.91M | 308.40M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -224.00K | -199.00K | -173.00K | -147.00K | -121.00K |
| Total Equity | 202.49M | 223.57M | 241.43M | 274.77M | 308.28M |
|
|
|||||
